UAE patient at home testing kits market is anticipated to grow at a robust CAGR during the forecast period, 2023-2027. Increased prevalence of diabetes and other chronic disorders and growing health awareness among consumers are the primary factors driving the demand for UAE patient at home testing kits market.

Also, the advent of innovative solutions to increase the accuracy and reduce the testing time of kits coupled with a rise in the number of market players offering affordable testing kits are expected to accelerate the UAE patient at home testing kits market growth for the next five years.

Rise in Prevalence of Diabetes Drives the Market Growth

According to the reports published by International Diabetes Federation (IDF), the number of people suffering from Diabetes Mellitus (DM) is expected to be around 300 million by 2025. Diabetes happens due to high levels of glucose which is called hyperglycemia, and is a kind of multifactorial disease that can be caused by genetic or environmental factors. Diabetes is considered a risk factor for many cardiovascular diseases such as stroke, myocardial infarction, and angina.

Adoption of a sedentary lifestyle and unhealthy eating habits is fueling the occurrence of diabetes among people. Diabetes has serious health consequences, including morbidity and mortality among patients, requiring immediate treatment to prevent risky health complications. The launch of patient at-home testing kits is a boon for diabetic patients as these tests give accurate results in a short duration of time and require a meager amount of blood samples.

Immediate checking of diabetes at home can make the patients aware of taking appropriate steps to lower the chances of any further health consequences. Market players are offering affordable and accurate patient at-home testing kits and adopting attractive marketing strategies to lure customers into buying diabetic testing kits of their brand.

The growing prevalence of diabetes and increased health awareness among consumers are expected to accelerate the demand for UAE patient at home testing kits market through the next five years.

Emergence of Online Sales Channel Supports the High Market Demand

Due to high internet penetration and the proliferation of smart devices, consumers have started to buy through the online sales channel. Online pharmacy stores are being considered highly convenient for customers as they provide quick doorstep delivery and lucrative discounts on patient at-home testing kits.

Online platforms like Aster pharmacy, Medicina Online Pharmacy, Life Pharmacy, and other platforms boast of delivering the testing kits in a matter of minutes. The rise in the number of market players offering products and efforts to improve the stock and supply chain by the market players to attract customers are expected to bolster the UAE patient at home testing kits market growth throughout the forecast period.


Click here to download the sample

Market Segmentation

The UAE patient at home testing kits market is segmented into test type, sample, usage, distribution channel, regional distribution, and company.

Based on test type, the market is divided into blood glucose testing, pregnancy & fertility testing, cholesterol testing, COVID-19 testing, urine testing, and others.

Based on sample, the market is divided into blood, urine, saliva/swab, and others. Based on usage, the market is divided into reusable v/s disposable.

Based on distribution channel, the market is divided into retail pharmacy stores, hypermarket/supermarket, e-commerce. To analyze the market based on the region, the UAE patient at home testing kits market is studied in major regions namely Dubai, Abu Dhabi, Sharjah, and Rest of the UAE.

Market Players

Abbott Laboratories, SA (UAE), Roche Diagnostics Middle East FZCO, Siemens Healthineers UAE, Quidel Corporation, GE Healthcare UAE, Procter & Gamble Middle East FZE, Swiss Precision Diagnostics GmbH (Clearblue), First Response, are among the major market players operating in the UAE patient at home testing kits market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Ownership

·         Type

·         Type of Services

·         Bed Capacity

Regional scope

Dubai, Abu Dhabi, Sharjah, Rest of UAE

Key companies profiled

Abbott Laboratories, SA (UAE), Roche Diagnostics Middle East FZCO, Siemens Healthineers UAE, Quidel Corporation, GE Healthcare UAE, Procter & Gamble Middle East FZE, Swiss Precision Diagnostics GmbH (Clearblue), First Response

Customization scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, UAE patient at home testing kits market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • UAE Patient At Home Testing Kits Market, By Test Type:
    • Blood Glucose Testing
    • Pregnancy & Fertility Testing
    • Cholesterol Testing
    • COVID-19 Testing
    • Urine Testing
    • Others
  • UAE Patient At Home Testing Kits Market, By Sample:
    • Blood
    • Urine
    • Saliva/Swab
    • Others
  • UAE Patient At Home Testing Kits Market, By Usage:
    • Reusable
    • Disposable
  • UAE Patient At Home Testing Kits Market, By Distribution Channel:
    • Retail Pharmacy Stores
    • Hypermarket/Supermarket
    • E-Commerce
  • UAE Patient At Home Testing Kits Market, By Region:
    • Dubai
    • Abu Dhabi
    • Sharjah
    • Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE patient at home testing kits market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

UAE patient at home testing kits market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on UAE Patient At Home Testing Kits Market

4.    Executive Summary

5.    Voice of Customers

6.    UAE Patient At Home Testing Kits Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine Testing, Others)

6.2.2.     By Sample (Blood, Urine, Saliva/Swab, Others)

6.2.3.     By Usage (Reusable v/s Disposable)

6.2.4.     By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    UAE Reusable Patient At Home Testing Kits Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Test Type

7.2.2.     By Sample

7.2.3.     By Distribution Channel

8.    UAE Disposable Patient At Home Testing Kits Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Test Type

8.2.2.     By Sample

8.2.3.     By Distribution Channel

9.    Market Dynamics

9.1.     Drivers

9.2.     Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  UAE Economic Profile

13.  Competitive Landscape

13.1.    Competition Outlook

13.2.    Company Profiles

13.2.1.  Abbott Laboratories, SA (UAE)

13.2.2.  Roche Diagnostics Middle East FZCO

13.2.3.  Siemens Healthineers UAE

13.2.4.  Quidel Corporation

13.2.5.  GE Healthcare UAE

13.2.6.  Procter & Gamble Middle East FZE

13.2.7.  Swiss Precision Diagnostics GmbH (Clearblue)

13.2.8.  First Response

14.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]